1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Calming and Sleeping in Slovakia

Calming and Sleeping in Slovakia

  • July 2015
  • -
  • Euromonitor International
  • -
  • 22 pages

The demand for sleeping products remained similar as before in Slovakia and the category recorded only 1% value sales growth in 2014. Calming and sleeping remains a niche area, accounting for sales of €3 million in 2014. Problems in work or families, excessive mental stress, wrong eating habits and drinking too many alcoholic or caffeinated beverages are often the main reasons for disturbing proper sleep and forcing consumers to look for aids to deal with this.

Euromonitor International's Calming and Sleeping in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

Calming and Sleeping in Slovakia
CALMING AND SLEEPING IN SLOVAKIA
Euromonitor International
July 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2009-2014
Table 2 Sales of Calming and Sleeping: % Value Growth 2009-2014
Table 3 NBO Company Shares of Calming and Sleeping: % Value 2010-2014
Table 4 LBN Brand Shares of Calming and Sleeping: % Value 2011-2014
Table 5 Forecast Sales of Calming and Sleeping: Value 2014-2019
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2014-2019
Walmark Spol Sro in Consumer Health (slovakia)
Strategic Direction
Key Facts
Summary 1 Walmark spol sro: Key Facts
Summary 2 Walmark spol sro: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Walmark spol sro: Competitive Position 2014
Executive Summary
Consumer Health Records Marginal Positive Growth in 2014
OTC Products Gain Stronger Ground at the Expanse of Rx Drugs
Zentiva Remains As Most Successful Company in 2014
Chemists/pharmacies Continues To Dominate the Retail Distribution in 2014
Positive Performance of Consumer Health Is Expected
Key Trends and Developments
the Sale of Consumer Health Through Internet Gains Importance
Consumers' Interest in Healthcare Begins To Change
the Performance of Domestic Manufacturers Remains Limited
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 4 OTC: Switches 2012-2014
Definitions
Sources
Summary 5 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

OTC

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.